Intrinsiqq
QHSLab Inc. logo

QHSLab Inc. Intrinsic Value

USAQ

⊜ Compare

Choose a model

Each card values QHSLab a different way, shown at our starting inputs. Pick one to see and change how it works.

Set your assumptions

QHSLab on earnings: earnings per share grow for a few years, then the stock trades at a normal price-to-earnings multiple.

Years to project

Growth of earnings per share

Earnings per share; not enough history; starts at 5%

Exit P/E

Starts at its industry's median P/E

Your desired return

Margin of safety

More

Your buy price

The expected return is measured from it; starts at today's price

How it's worked out

  1. Today's earnings per share

    Diluted EPS of $0.03 as filed, last twelve months, lowered to what operating profit after tax supports (one-off gains left out)

    $0.00

  2. Earnings in 2031

    Grows 5.0% a year for 5 years

    $0.01

  3. Price in 2031

    $0.01 × 20.4 P/E

    $0.11

  4. Worth today

    ÷ 1.10^5: your 10% a year, taken back out

    $0.07

  5. Fair value

    The most you can pay and still earn 10% a year

    $0.07

  6. Buy below

    Fair value minus your 25% margin of safety

    $0.05

Paying $0.32 instead gives -19.8% a year. Every rule is on the methodology page.

Outcome

What your assumptions give, and the path from today's price.

Fair value

$0.07

Expected return

-19.8% a year

Future price, 2031

$0.11

Buy below

$0.05

Price 386% above fair valuePrice $0.32, at your 10% return

Projection

Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.

QHSLab (USAQ) intrinsic value and fair value

The calculator grows one of QHSLab's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for USAQ; this is analysis, not investment advice.

Frequently asked

What is QHSLab's (USAQ) intrinsic value?+

With Intrinsiqq's starting inputs, QHSLab's fair value is about $0.07 a share, based on its earnings per share. That assumes earnings per share of $0.00 grows about 5.0% a year for 5 years, the stock then trades at 20.4 times earnings, and you want a 10.0% yearly return. On its other figures: revenue $0.37. Every input can be changed on the page; the result is a model, not a forecast.

Is QHSLab overvalued?+

At $0.32, the price is 386% above that fair value of $0.07, and buying at today's price would return about -19.8% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from SEC filings, not investment advice.

What growth does the QHSLab valuation assume?+

Earnings per share grows about 5.0% a year to start, a default, because there is too little history. The exit multiple starts at its industry's median.

What is a good margin of safety for QHSLab?+

A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at $0.05. Less predictable businesses deserve a wider cushion, or a higher desired return.

How the market compares: US profitability statistics

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with USAQ

CompareIntrinsic value
ICCMIceCure Medical Ltd.
$0.79+2.54%43
FEMYFemasys Inc.
$1.44+2.86%30
RNXTRenovoRx Inc.
$1.31+1.55%40
VTAKCatheter Precision, Inc.
$0.56-5.08%40
PSTVPlus Therapeutics Inc
No recent price28
INBSIntelligent Bio Solutions Inc.
$1.75-1.13%40
OSRHOsr Holdings Inc.
$0.16-5.88%10
VYCOVycor Medical Inc.
$0.05-3.85%50

Spot a number that looks wrong? Check it in USAQ's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing USAQ

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.